Functional relationships between serum total cholesterol levels, executive control, and sustained attention

Nutritional Neuroscience

Volumn 11, Issue 2, 2008, Pages 84-94

  Gendle, Mathew H ^a   Spaeth, Andrea M ^a   Dollard, Sarah M ^a   Novak, Cindy A ^a  

^a ELON UNIVERSITY   (United States)

Author keywords

Cognition; Executive control; Stress; Sustained attention; Total cholesterol

Indexed keywords

CHOLESTEROL;

ADULT; ALERTNESS; ANALYSIS OF COVARIANCE; ARTICLE; ATTENTION DISTURBANCE; BEHAVIOR; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION FUNCTION; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIFE STRESS; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ATTENTION; BEHAVIOR; BODY MASS INDEX; CHOLESTEROL; COGNITION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; STRESS, PSYCHOLOGICAL;

EID: 50449095913     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683008X301469     Document Type: Article

References (94)

1. Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr 2004; 24: 401-431.
2. Prentice AM, Jobb SA. Fast foods, energy density, and obesity: A possible mechanistic link. Obes Rev 2003; 4: 187-194.
3. Astrup A. Super-sized and diabetic by frequent fast food consumption? Lancet 2005; 365: 4-5.
4. Greenwood CE, Winocur G. Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 1990; 53: 74-87.
5. Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: A specific effect of saturated fatty-acid intake. Behav Neurosci 1996; 110: 451-459.
6. Winocur G. Greenwood CE. High-fat diets impair conditional discrimination learning in rats. Psychobiology 1993; 21: 286-292.
7. Winocur G, Greenwood CE. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999; 101: 153-161.
8. Benton D. Dietary fat and cognitive functioning. In: Hillbrand M, Spitz RT. (eds) Lipids, Health, and Behavior. Washington, DC: American Psychological Association, 1997; 227-243.
9. Kaplan JR, Greenwood CE. Dietary saturated fatty acids and brain function. Neurochem Res 1998; 23: 615-626.
10. Dye L, Lluch A, Blundell JE. Macronutrients and mental performance. Nutrition 2000; 16: 1021-1034.
11. Meltoni R, Bernard RJ, Ying Z, Roberts CK, Gomez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002; 112: 803-814.
12. Wu A, Molteni R, Ying Z, Gomez-Pinilla F. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 2003; 119: 365-375.
13. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001; 12: 105-112.
14. Rogers PJ. A healthy body, a healthy mind: Long term impact of diet on mood and cognitive function. Proc Nutr Soc 2001; 60: 135-143.
15. Michikawa M. Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res 2003; 72: 141-146.
16. Muldoon MF, Barger SD, Ryan CM et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108: 538-546.
17. Wardle J, Rogers P, Judd P et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med 2000; 108: 547-553.
18. Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 2003; 74: 1530-1535.
19. Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 2005; 24: 42-50.
20. Benton D. Do low cholesterol levels slow mental processing? Psychosom Med 1995; 57: 50-53.
21. Muldoon MF, Ryan CM, Matthews KA, Manuck SB. Serum cholesterol and intellectual performance. Psychosom Med 1997; 59: 382-387.
22. Elias PK, Elias MF, D'Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med 2005; 67: 24-30.
23. Zhang J, Muldoon MF, McKeown RE. Serum cholesterol concentrations are associated with visuomotor speed in men: Findings from the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2004; 80: 291-298.
24. Puttonen S, Elovainio M, Kivimäki M, Lehtimäki T, Keltikangas-Järvinen L. The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults. Neuropsychobiology 2003; 48: 35-40.
25. Reitan RM, Shipley RE. The relationship of serum cholesterol changes to psychological abilities. J Gerontol 1963; 18: 350-356
26. Kaplan JR, Manuck SB, Shively C. The effects of fat and cholesterol on social behavior in monkeys. Psychosom Med 1991; 53: 634-642.
27. Kaplan JR, Manuck SB, Fontenot MB, Muldoon MF, Shively CA, Mann JJ. The cholesterol-serotonin hypothesis interrelationships among dietary lipids, central serotonergic activity, and social behavior in monkeys. In: Hillbrand M, Spitz RT. (eds) Lipids, Health, and Behavior. Washington, DC: American Psychological Association, 1997; 139-165.
28. Mason RP, Herbette LG, Silverman DI. Can altering serum cholesterol affect neurologic function? J Mol Cell Cardiol 1991; 23: 1339-1342.
29. Pozzi F, Troisi A, Cerilli M et al. Serum cholesterol and impulsivity in a large sample of healthy young men. Psychiatry Res 2003; 120: 239-245.
30. Kaplan JR, Shively CA, Fontenot MB et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 1994; 56: 479-484.
31. Arnsten AFT, Goldman-Rakic PS. Noise stress impairs prefrontal cortical cognitive function in monkeys. Arch Gen Psychiatry 1998; 55: 362-368.
32. Arnsten AFT. Development of the cerebral cortex: XIV. Stress Impairs prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 1999; 38: 220-222.
33. Arnsten AFT. Stress impairs prefrontal cortical function in rats and monkeys: Role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog Brain Res 2000; 126: 183-192.
34. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AFT. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 1999; 46: 1266-1274.
35. Sapolsky RM. Why stress is bad for your brain. Science 1996; 273: 749-750.
36. Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab [serial online] 2005; 2: Article 3. [Accessed 20 July 2005].
37. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001; 2: 73-86.
38. Bjorntorp P. Rosmond R. The metabolic syndrome - A neuroendocrine disorder? Br J Nutr 2000; 83: S49-S57.
39. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue related causes. Int J Obes 2000; 24: S50-S55.
40. Oliver G, Wardle J, Gibson EL. Stress and food choice: A laboratory study. Psychosom Med 2000; 62: 853-865.
41. Cholectech Corporation. The accuracy and reproducibility of a rapid, fingerstick method for measuring a complete lipid profile is comparable to a reference laboratory method (Technical Brief MKT12269 rev. B). Hayward, CA: Cholestech Corporation, 2003. [accessed 22 July 2005].
42. Ose L, Aass B, Christophersen B. [A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids]. Tidsskr Nor Laegeforen 1995; 115: 3487-3489.
43. Issa JS, Strunz C, Giannini SD, Forti N, Diament J. [Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)]. Arq Bras Cardiol 1996; 66: 339-342.
44. Volles DF, McKenney JM, Miller WG, Ruffen D, Zhang D. Analytic and clinical performance of two compact cholesterol-testing devices. Pharmacotherapy 1998; 18: 184-192.
45. Santee J. Accuracy and precision of the Cholestech LDX system in monitoring blood lipid levels. Am J Health Syst Pharm 2002; 59: 1774-1779.
46. Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA. Inaccuracy of lipid measurements with the portable Cholestech LDX analyzer in patients with hypercholesterolemia. Clin Chem 2002; 48: 284-290.
47. Rubin DA, McMurray RG, Harrell JS, Carlson BW, Bangdiwala S. Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification. Int J Sport Nutr Exerc Metab 2003; 13: 358-363.
48. Panz VR, Raal FJ, Paiker J, Immelman R, Miles H. Performance of the CardioChek™ PA and Cholestech LDX® point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J South Afr 2005; 16: 112-115.
49. Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta 2006; 367: 69-76.
50. Moos RH, Moos BS. Life Stressors and Social Resources Inventory Adult Form Professional Manual. Lutz, FL: Psychological Assessment Resources, 1994.
51. Moos RH, Fenn CB, Billings AG. Life stressors and social resources: An integrated assessment approach. Soc Sci Med 1988; 27: 999-1002.
52. Shallice T. Specific impairments in planning. Philos Trans R Soc Lond B Biol Sci 1982; 298: 199-209.
53. DX: A standardized approach to assessing executive functioning in children. Arch Clin Neuropsychol 1998; 13: 285-301.
54. DX) technical manual. North Tonawanda, NY: Multi-Health Systems, 2005.
55. Lewis RF. Digit Vigilance Test Professional User's Guide. Lutz, FL: Psychological Assessment Resources, 1995.
56. Kelland DZ, Lewis RF. The Digit Vigilance Test: Reliability, validity, and sensitivity to diazepam. Arch Clin Neuropsychol 1996; 11: 339-344.
57. Canfield RL, Gendle MH, Cory Sleehta DA. Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol 2004; 26: 513-540.
58. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-137.
59. Posner MI, Peterson SE. The attention system of the human brain. Annu Rev Neurosci 1990; 13: 25-42.
60. Goel V, Grafman J. Are the frontal lobes implicated in 'planning' functions? Interpreting data from the Tower of Hanoi. Neuropsychologia 1995; 33: 623-642.
61. Baker SC, Rogers RD, Owen AM, et al. Neural systems engaged by planning: A PET study of the Tower of London task. Neuropsychologia 1996; 34: 515-526.
62. Granon S, Hardouin J, Courtiere A, Poucet B. Evidence for the involvement of the rat prefrontal cortex in sustained attention. Q J Exp Psychol 1998; 51B: 219-233.
63. Rowe JB, Owen AM, Johnsrude IS, Passingham RE. Imaging the mental components of a planning task. Neuropsychologia 2001; 39: 315-327.
64. Sarter M, Givens B, Bruno JP. The cognitive neuroscience of sustained attention: Where top-down meets bottom-up. Brain Res Rev 2001; 35: 146-160.
65. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: The Framingham Heart Study. Int J Obes 2003; 27: 260-268.
66. Cournot M, Marquié J-C, Ansiau D et al. between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006; 67: 1208-1214.
67. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
68. Kuller LH. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 2004; 15: 109-113.
69. Forouhi NG, Sattar N. CVD risk factor and ethnicity A homogeneous relationship?. Atheroscler Suppl 2006; 7: 11-19.
70. Lloyd HM, Green MW, Rogers PJ. Mood and cognitive performance effects of isocaloric lunches differing in fat and carbohydrate content. Physiol Behav 1994; 56: 51-57.
71. Dubois C, Armand M, Mekki N et al. Effects on increasing amounts of dietary cholesterol on postprandial lipemia and lipoproteins in human subjects. J Lipid Res 1994; 35: 1993-2007.
72. Dubois C, Beaumier G, Juhel C et al. Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1998; 67: 31-38
73. Lairon, D. Nutritional and metabolic aspects of postprandial lipemia. Reprod Nutr Dev 1996; 36: 345-355.
74. Dubois C, Armand M, Azais-Braesco V et al. Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1994; 60: 374-382.
75. Dubois C, Armand M, Ferezou J et al. Postprandial appearance of dietary deuterated cholesterol in the cylomicron fraction and whole plasma in healthy subjects. Am J Clin Nutr 1996; 64: 47-52.
76. Bergeron N, Havel RJ. Assessment of postprandial lipemia: Nutritional influences. Curr Opin Lipidol 1997; 8: 43-52.
77. Lloyd HM, Rogers PJ, Hedderly DI, Walker AF. Acute effects on mood and cognitive performance of breakfasts differing in fat and carbohydrate content. Appetite 1996; 27: 151-164.
78. Vance JE, Hayashi H, Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 2005; 16: 193-212.
79. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
80. Flordellis CS, Ilias I, Papavassiliou AG. New therapeutic options for the metabolic syndrome: What's next? Trends Endocrinol Metab, 2005; 16: 254-260.
81. Herz J, Beck HH. Lipoprotein receptors in the nervous system. Annu Rev Biochem 2002; 71: 405-434.
82. Bjorkhem I, Meaney S. Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806-815
83. Dehouck B, Fenart L, Dehouck M-P, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138: 877-889.
84. Fagan AM, Younkin LH, Morris JC et al. Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 2000; 48: 201-210.
85. Fassbender K, Stroick M, Bertsch T et al. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 2002; 59: 1257-1258.
86. Qiu S, Korwek KM, Weeber EJ. A fresh look at an ancient receptor family: Emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol Learn Mem 2006; 85: 16-29.
87. Kessler AR, Kessler B, Yehuda S. Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and a plant oil mixture. Biochem Pharmacol 1985; 34: 1120-1121.
88. Kessler AR, Kessler B, Yehuda S. In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indications for interactions between hippocampal-cortical cholesterol and learning. Life Sci 1986; 38: 1185-1192.
89. Fuster JM. The Prefontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. Philadelphia, PA: Lippincott-Raven, 1997.
90. Fuster JM. Executive frontal functions. Exp Brain Res 2000; 133: 66-70.
91. Fuster JM, Bodner M, Kroger JK. Cross-modal and cross-temporal association in neurons of frontal cortex. Nature 2000; 405: 347-351.
92. Kimberg DY, D'Esposito MD, Farah MJ. Cognitive functions in the prefrontal cortex-working memory and executive control. Curr Dir Psychol Sci 1998; 6: 185-192.
93. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167-202.
94. Constanidis C Williams GV, Goldman Rakie PS. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 2002; 5: 175-180.